Average cost of multi drug-resistant tuberculosis treatment in Sri Lanka
Sri Lanka: Average cost of multi drug-resistant tuberculosis treatment was 902 constant 2022 US$ in 2024. ◆ Volatile
Latest (2024)
902 constant 2022 US$
Change on year
up 1.0%
World rank
52nd
of 92 countries
All-time high
4,976 constant 2022 US$
in 2019
All-time low
893 constant 2022 US$
in 2023
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in Sri Lanka, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2024, average cost of multi drug-resistant tuberculosis treatment in Sri Lanka stood at 902 constant 2022 US$.
Compared with earlier readings it is up 1.0% on the previous year and down 31.2% over ten years.
Sri Lanka ranks 52nd of 92 countries on this measure, in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Sri Lanka, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 1,311 constant 2022 US$ | — |
| 2018 | 1,797 constant 2022 US$ | +37.1% |
| 2019 | 4,976 constant 2022 US$ | +176.9% |
| 2020 | 2,402 constant 2022 US$ | -51.7% |
| 2021 | 1,055 constant 2022 US$ | -56.1% |
| 2022 | 1,945 constant 2022 US$ | +84.4% |
| 2023 | 893 constant 2022 US$ | -54.1% |
| 2024 | 902 constant 2022 US$ | +1.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,695 constant 2022 US$ | 1,311 constant 2022 US$ | 4,976 constant 2022 US$ | 3 |
| 2020s | 1,439 constant 2022 US$ | 893 constant 2022 US$ | 2,402 constant 2022 US$ | 5 |
Countries ranked near Sri Lanka
- 50 Gabon 995 constant 2022 US$ compare
- 51 Papua New Guinea 953 constant 2022 US$ compare
- 53 Botswana 900 constant 2022 US$ compare
- 54 Congo, Democratic Republic of the 896 constant 2022 US$ compare
- 55 Bhutan 886 constant 2022 US$ compare
More health data for Sri Lanka
- Un projection of annual infant deaths, annual growth rate -1.62 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7332 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,250 deaths per 1,000 people (2090)
- Number of infants who die before age 1 304 deaths (2100)
- Population ages 65-69, male, annual growth rate 1.07 % change on previous year (2025)
- Population ages 65-69, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65-69, male, per capita 0.0197 units per person (2025)
- Population ages 70-74, female, annual growth rate 0.7895 % change on previous year (2025)
- Population ages 70-74, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 70-74, female, per capita 0.0202 units per person (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Sri Lanka?
- Average cost of multi drug-resistant tuberculosis treatment in Sri Lanka was 902 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Sri Lanka?
- The highest recorded value was 4,976 constant 2022 US$ in 2019.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Sri Lanka?
- The lowest recorded value was 893 constant 2022 US$ in 2023.
- How does Sri Lanka rank for average cost of multi drug-resistant tuberculosis treatment?
- Sri Lanka ranks 52nd out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Sri Lanka?
- Over the last ten years it is down 31.2%. The long-run trend across the full record is volatile.
- Where does this Sri Lanka data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.